ClearPoint Neuro (CLPT) Cash from Investing Activities (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Cash from Investing Activities data on file, last reported at -$645000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 252.46% year-over-year to -$645000.0; the trailing twelve-month figure through Mar 2026 stood at $153000.0 (up 133.41% YoY), and the FY2025 full-year result was $615000.0, up 323.64% from the prior year.
• Cash from Investing Activities fell to -$645000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $11.7 million in Q4 2022 to a low of -$21.7 million in Q2 2022.
• A 5-year average of -$139466.7 and a median of -$185000.0 in 2022 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 31010.53% in 2022, while the deepest fall reached 62002.86% in 2022.
• Tracing CLPT's Cash from Investing Activities over 5 years: stood at $11.7 million in 2022, then plunged by 101.6% to -$188000.0 in 2023, then tumbled by 39.89% to -$263000.0 in 2024, then soared by 513.69% to $1.1 million in 2025, then sank by 159.28% to -$645000.0 in 2026.
• Business Quant data shows CLPT's Cash from Investing Activities at -$645000.0 in Q1 2026, $1.1 million in Q4 2025, and -$199000.0 in Q3 2025.